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The aim of the present work was to assess the adherence to medication from polymedicated patients 
before and after the use of a Drug-dispensing System with Usage Control (DDSUC) and compare 
the levels of the clinical parameters – blood pressure, postprandial glycemia, glycated hemoglobin, 
triglycerides and cholesterol. DDSUC consisted of a monthly drug-dispensing package, in the shape of 
a blister with a calendar. This quasi-experimental study was performed in a Basic Health Unit. Twenty 
four patients were selected to use DDSUC for 4 months. Medication adherence was assessed through 
Morisky-Green test. Among the participants of the study, 62.5% were women and the average age was 
67 years old. Before the use of DDSUC, 83.3% of the patients were considered as “less adherent”. After 
the use of the system, 100% were considered as “more adherent” (p < 0.01), the means of the systolic 
blood pressure decreased 23.7 mmHg (p=0.000), the diastolic blood pressure decreased 12.1 mmHg 
(p=0.004) and glycemia diminished 79.3 mg/dl (p=0.000). The use of DDSUC improved the adherence 
to medication and decreased the values of the clinical parameters, making patients safer when it comes 
to respecting the correct use of their medication.
Uniterms: Medication/treatment adherence. Medicines/safety use. Medicines/dispensing. Drug-
Dispensing System and Use Control. Polymedication.
O objetivo deste estudo foi avaliar a adesão ao tratamento medicamentoso de pacientes polimedicados 
antes e após o uso de um Sistema de Dispensação de Medicamentos e Controle de Uso (SDMCU) 
e comparar os níveis dos parâmetros clínicos - pressão arterial, glicemia pós-prandial, hemoglobina 
glicada, triglicérides e colesterol. O SDMCU foi constituído por uma embalagem mensal de dispensação 
de medicamentos, em forma de blister com calendário. Este estudo, do tipo quase-experimental, foi 
realizado em uma Unidade Básica de Saúde. Selecionaram-se 24 pacientes para utilizar o SDMCU por 4 
meses. A adesão medicamentosa foi avaliada através do Teste de Morisky e Green. Entre os participantes 
do estudo, 62,5% eram mulheres e a idade média foi de 67 anos. Antes do uso do SDMCU, 83,3% dos 
pacientes foram considerados “menos aderentes”. Após o uso do sistema, 100% foram considerados “mais 
aderentes” (p<0,01), a média da pressão arterial sistólica diminuiu 23,7 mmHg (p=0,000), a diastólica 
diminuiu 12,1 mmHg (p=0,004) e a glicemia diminuiu 79,3 mg/dL (p=0,000). O uso do SDMCU melhorou 
a adesão medicamentosa e diminuiu os valores dos parâmetros clínicos, proporcionando aos pacientes 
uma segurança no que diz respeito à utilização correta de seus medicamentos.
Unitermos: Medicação/adesão ao tratamento. Medicamentos/uso seguro. Medicamentos/dispensação. 
Sistema de Dispensação de Medicamentos e Controle de Uso. Polimedicação.
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INTRODUCTION
The World Health Organization defines adherence 
as the extent to which the behavior of a person towards the 
proposed treatment responds to recommendations made 
by health professionals (WHO, 2003; Haynes et al., 2008; 
Ahmed, Aslani, 2014). The lack of adherence to treatment 
is a widely recognized major problem both in the national 
and international scenarios. The average adherence rate of 
patients to treatment in developed countries is as low as 
50%, whereas in developing countries this percentage is 
even lower (WHO, 2003; Ahmed, Aslani, 2014).
Non-adherence to pharmacological treatment 
consists of not using the drug in the correct dose, either 
by forgetting or by not respecting the dose frequency 
and/or discontinuing treatment before the recommended 
time. Non-adherence to the prescribed treatment has been 
responsible for the increase in hospitalization and health 
service costs (Sokol, 2005). Studies performed in the USA 
have showed that 33 to 69% of all hospitalizations were 
due to the low adherence to the pharmacological treatment 
prescribed, resulting in a cost of around US$100 billion 
per year to the health system (Braithwaite et al., 2013; 
Osterberg, Blaschke, 2005).
Adherence is a multi-dimensional phenomenon 
influenced by several factors (Santos et al., 2013; WHO, 
2003). Among the reasons identified in literature to non-
adherence to medication are: side effects of the drugs, 
forgetfulness to take them, economic cost, fear for 
interaction with alcohol and other drugs, no awareness of 
the necessity of the treatment continuity; use of alternative 
treatments and fear for intoxication (Cavalari et al., 2012; 
Nair et al., 2011). Nevertheless, some researchers consider 
that the capacity of understanding and the knowledge 
in health of the patients may interfere positively in the 
treatment adherence (Zhang, Terry, Mchorney, 2014).
Furthermore, the presence of chronic diseases and 
the use of multiple medications are some of the various 
factors affecting adherence (WHO, 2003). The use of 
five or more medications, also known as polypharmacy, 
is associated with an increased risk and severity of 
adverse drug reactions, precipitation of pharmacological 
interactions, medication errors and especially the reduction 
of treatment adherence as well as the increase of morbidity 
and mortality (Secoli, 2010).
However, polipharmacy is a common practice 
within the health system, especially among elderly 
patients diagnosed with chronic diseases. Likewise, 
several factors may contribute to polypharmacy, such as 
a high prevalence of health problems, elevated number of 
doctors’ appointments and self-medication (Baldoni et al., 
2013). That shows the need to adopt clinical intervention 
and educational and managerial measures to analyze and 
promote rationality in the use of drugs among the users of 
the Brazilian Public Health System (Baldoni et al., 2013).
Among the proposed strategies and devices to 
improve medication adherence are: educational instruction 
for the patient (on diseases, treatments and lifestyle); 
educational assistance for health professionals; the supply 
of dispensing systems (electronic monitoring, blister 
packs, drug organizers); self-monitoring and recording of 
blood pressure; medication reminders (guidelines, phone 
calls and visits from a clinical pharmacist) (Zedler et al., 
2011; Haynes et al., 2008). Most of these interventions 
show an improvement in adherence to medication, but few 
have significant results (Morgado et al., 2011; Zedler et al., 
2011; Haynes et al., 2008; Connor, Rafter, Rodgers, 2004).
Among the strategies mentioned previously, one 
can point out that the blister with calendar is a pack in 
which each pill is labeled with weekdays or month dates, 
providing a visual record of when the patient took the 
last pill (Zedler et al., 2011). Each blister may contain 
single or multiple drugs (Ruppar, Conn, Russell, 2008; 
Zedler et al., 2011). Drugs organized in blister packs, 
especially combined with orientation, may help patients 
to use their medication correctly, decrease medication 
errors and increase adherence to drug treatment (Zedler 
et al., 2011).
Thus, the present work was based on the following 
hypothesis: the patients increased the adherence to 
medication after the use of a Drug-dispensing System 
with Usage Control (DDSUC). Considering the great 
quantity of drugs used in the treatment of chronic diseases, 
the difficulties from patients to keep adherence to the 
treatment and also the complications of the disease due 
to this lack of adherence, the present study aimed at 
evaluating adherence to drug treatment of polymedicated 
patients, before and after the use of a Drug-Dispensing 
System with Usage Control (DDSUC); also, we aimed 
at comparing the blood pressure levels, postprandial 
glycemia, glycated hemoglobin, triglycerides and 
cholesterol, between pre- and post-intervention.
MATERIAL AND METHODS
Location and study design
This is a quasi-experimental study conducted in a 
Pharmacy of the Brazilian Public Health System of Luiz 
Antônio, a town with 11,286 inhabitants in the inner area 
of the São Paulo state, Brazil (IBGE, 2013). The study was 
approved by the Research Ethics Committee of the Faculty 
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of Pharmaceutical Sciences of Ribeirão Preto, University 
of São Paulo (protocol CEP/FCFRP No. 121).
Patients
From the database of the city´s information system, 
a spreadsheet was generated using the Excel® program, 
containing the list of registered patients and drugs 
dispensed to them from August to December 2007. That 
survey showed that 6,573 patients attended the outpatient 
pharmacy during this period, adding up to 58.2% of the 
city population.
The inclusion criteria were: patients using 
polypharmacy, taking at least five different medications 
continuously to treat chronic diseases such as hypertension, 
diabetes mellitus, hypercholesterolemia and cardiovascular 
disease; patients that used monthly the services of the 
pharmacy from the Brazilian Public Health System, and 
that were under medical follow-up. The exclusion criteria 
were: individuals younger than 18 years old and those 
unable to manage their own medications, being dependent 
on others to do so.
Intervention
In order to contribute to the medication treatment 
adherence and also to the safety of the polypharmacy 
patients, we developed the Drug-Dispensing System with 
Usage Control (DDSUC). The system is formed by a blister 
pack customized with written information containing the 
patient’s name, the names of the medications and method 
of use. Each blister contains 30 compartments, which 
comprise the medication for a particular time of the day 
for a month of treatment. The blisters contain labels with 
icons that represent the timetable, such as the sun to show 
the day, the moon to show the night and food dishes to 
direct for the use of drugs together with meals.
For example, if the patient needs to take 5 pills at 
7 am, they are together in the same compartment of the 
blister pack with the icon of the sun, ready for a month 
of use. The packs can be prepared for various times of 
the day, according to prescription and patient needs. For 
the protection of the photo-sensitive medication, amber-
colored blisters are used. The blisters are marked from the 
1st to the 30th day of the month (Figure 1).
For the follow-up of the participants of this study, the 
DDSUC was prepared by the pharmaceutical researcher 
according to the routine of each patient. The medications 
were organized in blister packages during the monthly 
meeting with the patient, which took place in a reserved 
room at the pharmacy and that lasted around 1 hour for 
each participant per month. In this very meeting, the 
patients were instructed by the pharmacist on how to 
correctly use the DDSUC.
Before the preparations of the blisters, studies 
on medicament interactions were performed with 
Micromedex (2007), in order to avoid potentially 
serious interactions, ensuring the pharmacotherapy 
safety. Whenever the researcher found evidence for 
interaction or incompatibility of the drugs, those were 
placed in different blisters so that they could be used at 
different times. Neither were there interventions with the 
doctors nor the gathering of information concerning the 
pharmacotherapeutic problems, in an attempt to keep the 
study focused on the assessment of the DDSUC use.
Data collection
The period of data collection for the selected patients 
was four months with a total of six meetings which were 
conducted by the same researcher in a private room in the 
clinic, with a 60-minute average duration, to avoid any 
possible bias in the orientations and in the application of 
the data collection instrument among the patients.
In the first meeting, the guest participant in the 
study was asked to sign the consent form. At the same 
meeting, after acceptance to participate in the survey, 
socio-economic questionnaires were conducted, patients 
received information about medications they usually use (all 
FIGURE 1 - Drug-dispensing system with usage control for a 
month of use, at 7 in the morning.
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prescriptions were transcribed into an instrument containing 
the prescription date, the patient´s identification number, 
drug names, dosage, frequency, time and duration of use). 
Hence, they performed the Morisky-Green test (MGT).
The MGT is an instrument used to measure 
individual compliance of pharmacological treatment. 
The scoring of MGT responses is as follows: Yes = 0 
and No = 1. If all the answers are “no”, the score will be 
4 and if they are all “yes”, the score will be 0, indicating 
adherence to the medication (Morisky, Green, Levine, 
1986). This test was validated in the US in hypertensive 
patients, using blood flow control as the gold standard; it 
is also the most widely used questionnaire in Brazil (Bem, 
Neumann, Mengue, 2012).
In the second meeting after the first 30 days, the 
DDSUC was delivered for a month of treatment, and 
clinical parameters were measured (blood pressure, 
postprandial glycemia, triglycerides and cholesterol). 
Calibrated and accurate apparatus was used. The measure 
of the blood pressure was according to the technique 
described by the Brazilian Hypertension Guidelines 
(Sociedade Brasileira de Hipertensão, 2010).
In the other meetings, the DDSUC for monthly 
usage was delivered, clinical parameters were measured 
and the used packs were collected for usage control. The 
usage control was made through the pill count.
In the sixth and final meeting, the clinical parameters 
were measured; both the MGT and an instrument to assess 
the degree of patient satisfaction were applied to the 
DDSUC users.
The instrument to assess the degree of patient 
satisfaction consisted of four questions and aimed at 
assessing satisfaction towards the system for drug 
dispensation in custom blisters. Before asked, the 
questions for the study participants were analyzed by two 
experienced professionals in the area of knowledge related 
to this study and were then adapted to meet suggestions. 
This instrument was applied by a research assistant 
properly trained.
Participants with diabetes mellitus were asked to 
take a clinical examination of glycated hemoglobin (GH) 
in the first and last meeting, i.e. before and after using 
the DDSUC. That exam was performed at the clinical 
laboratory. The drugs used in this study were obtained 
monthly and provided to the patients free of charge in the 
local pharmacy of the Brazilian Public Health System.
Statistical analysis
The database was constructed in an Excel spreadsheet 
(version 2007) and double data entry and data validation 
were performed to identify possible errors. Descriptive 
statistics was used to analyze most variables and the results 
presented in terms of the absolute and relative frequency, 
mean ± standard deviation (SD) with 95% confidence 
intervals. Statistical analysis was performed using the 
SPSS software, version 16.0.
In order to determine the sample normality, 
Kolmogorov-Smirnov´s test was employed. For variables 
with normal distribution the “t Test” was applied, and 
for those which did not have normal distribution the 
“Wilcoxon Test” was performed (both for paired samples). 
P values ≤ 0.05 were considered significant.
RESULTS
Following the selection criteria, 352 patients were 
pre-selected and, among those, 50 men and 50 women 
were randomly selected. Next, a phone call was made to 
all those selected. The ones that answered the phone call 
and that had time availability were invited to a meeting 
at the pharmacy in order to be invited to take part in the 
research, after the signature of a Term of Free Consent 
and Understanding. Some could not participate and others 
were not found. Convenience sampling was used because 
due to the available search period, it was not possible to 
include all patients. This way, we selected 24 patients. 
Figure 2 shows the flow diagram of patient selection.
Among the 24 study participants, there was a 
predominance of 62.5% females, mean age 67 years (SD 
10.3), 54.2% were married, 79.2% retired, 54.2% received 
FIGURE 2 - Flow diagram of patient selection to use the Drug-
Dispensing System with Usage Control.
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1 to 3 minimum wages and 91.7% lived with their spouses 
or children. In relation to education, 25% were illiterate 
and 41.7% had 1 to 4 years of schooling.
Patients took an average of 8.4 (SD 2.9) different 
medicines per day for chronic use. In relation to the 
period of use, 29.1% of patients reported using for 1 to 7 
years, 37.5% for 7 to 19 years and 33.4% were using their 
medications for more than 20 years, thus portraying the 
characteristics of chronic disease.
Regarding comorbidities, 50% of patients had two 
diagnoses and 37.5% had three. The average diagnosis 
was 2.3 per patient. Among the 24 patients, 20.8% had 
hypertension and diabetes, 20.8% hypertension and high 
triglycerides, and 25% hypertension, diabetes and high 
triglycerides concurrently.
Before the use of the DDSUC, 83.3% of the patients 
were considered as “less adherent” by MGT; after the use, 
100% were considered as “more adherent”. After the use 
of the system, the means of the systolic blood pressure 
decreased 23.7 mmHg (p=0.000), the diastolic blood 
pressure decreased 12.1 mmHg (p=0.004), glycemia 
decreased 79.3 mg/dl (p=0.000) and glycated hemoglobin 
decreased 0.93% (p=0.011). That result shows that the 
DDSUC significantly improved adherence to therapy 
(Table I).
In relation to GH, 5 (38.46%) of the 13 (100%) 
patients with diabetes had a reduction of more than 1% in 
the GH value after use of the DDSUC. The average GH was 
8.7% before and 7.4% after using the system. The United 
Kingdom Prospective Diabetes Study demonstrated that 
reducing GH by 1%, chronic complications decrease 
significantly, decreasing the risk of microvascular 
complications by 35% and reducing deaths from diabetes 
by 25% (Sociedade Brasileira de Diabetes, 2009).
The analysis of the frequency and percentage 
of instrument variables to assess the degree of patient 
satisfaction using the DDSUC showed that only 8.3% 
of patients felt confused when using the DDSUC; 
95.8% would not like to return to the previous method 
of dispensing medications; 95.8% thought that the new 
method brought benefits to their lives and 100% would 
recommend the DDSUC to friends in a similar situation. 
Concerning the frequency and percentage score of the 
satisfaction degree of DDSUC users, among the 24 
patients interviewed, 87.5% (n=21) obtained the maximum 
score, i.e. they were very satisfied with the new method of 
medication dispensation.
DISCUSSION
It was observed that most of the patients in the 
study were elderly, i.e. were 60 years or older. Due to 
cognitive and physical changes associated with aging, the 
elderly population has an increased risk for problems with 
adherence to medication (Ruppar, Conn, Russell, 2008). 
Among adults aged 65 or older, the prevalence of patients 
with two or more chronic health problems is high (65%) 
and that leads to the frequent use of multiple medications 
(Wolff, Starfield, Anderson, 2002). Predictably, the 
complexity of these frequent-use regimes promotes non-
adherence to medication (Lee, Grace, Taylor, 2006).
Furthermore, the presence of three or more 
diagnoses, the clinical complexity of the patient with 
multiple diseases, metabolic changes and, consequently, 
TABLE I - Description and comparison of variables between the pre- and post-intervention, Luiz Antônio, SP, 2009
Time n Maximum Minimum SD* Median Average p-value
Systolic blood pressure Pre 24 180 110 19.39 150 147.50 0.000a
Post 24 140 110 8.75 120 123.75
Diastolic blood pressure Pre 24 130 50 17.44 95 92.08 0.004b
Post 24 100 70 6.59 80 80.00
Glycemia Pre 24 409 72 94.67 146.0 185.75 0.000a
Post 24 196 63 28.71 98.5 106.42
Glycated hemoglobin Pre 13 9.9 5.9 1.33 8.7 8.26 0.011a
Post 13 9.5 6.0 1.04 7.4 7.33
Cholesterol Pre 24 316 128 42.63 163.5 177.96 0.017b
Post 24 229 150 18.59 150.0 159.83
Triglycerides Pre 24 350 70 83.00 224.5 202.54 0.000b
Post 24 276 70 65.26 70.0 119.33
*Standard Deviation; aParametric tests (t Test); bNon-parametric tests (Wilcoxon Test) 
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the use of polypharmacy are factors that increase the 
chance of the occurrence of potential drug interactions, 
which can cause adverse drug reactions and contribute 
to the treatment failure and ineffective therapy (Spriet et 
al., 2009).
Non-adherence to medication is particularly 
problematic for asymptomatic conditions such as 
hypertension and hyperlipidemia. The lack of quick 
and easy access to the control parameters such as blood 
pressure, glycemia, cholesterol and triglycerides can lead 
to serious complications. The inadequacy of therapy, 
besides the increasing demand for health services, foments 
hospitalization and contributes to extend its duration 
(Nóbrega, Karnikowski, 2005), increasing healthcare costs 
(Sokol, 2005). Such conditions pose great challenges to the 
healthcare, opening up new horizons for research to enable 
patient monitoring in an effort to ensure adherence to drug 
therapy, and in particular, their safety and well-being.
Concerning the medication adherence, the number 
of participants with low adherence (83.3%), before the use 
of DDSUC, is similar to the results of a research performed 
with 90 hypertensive elders, aging 66 years old, in a Health 
Center in the town of Novo Horizonte – SP. The aim of 
that study was to assess the level of adherence to the 
medication treatment by TMG and, in that opportunity, 
the researchers found that 72.2% of the elders did not use 
their medication correctly (Eid et al., 2013).
However, similar studies of intervention using 
blister packs for the organization of drugs also showed 
positive results in improving adherence after the use of 
the intervention (Simmons, Upjohn, Gamble, 2000; Lee, 
Grace, Taylor, 2006). Simmons, Upjohn and Gamble 
(2000) performed a study to evaluate the impact of using 
a calendar blister pack for glycemia and blood pressure 
control. The randomized controlled study followed 68 
patients with low control of glucose for 8 months. The 
values of GH and blood pressure decreased in the group 
that used the blister pack, compared to the control group. 
In this study, the calendar blister pack showed that it is 
possible to improve metabolic and blood pressure control 
in patients taking multiple medications. In another study, 
Lee, Grace and Taylor (2006) also tested the efficacy of 
the use of a blister pack to organize medications associated 
with a clinical follow-up. After 6 months of intervention, 
adherence to medication increased and was associated 
with significant improvements in systolic blood pressure 
and cholesterol.
Ruppar, Conn and Russell (2008) conducted a 
literature review to identify randomized controlled trials 
of adherence to medication from literature published 
between 1977 and 2005. The literature review explored the 
variety and nature of 63 studies that tested interventions 
on medication adherence for adults over 60 years. Eleven 
of the 63 studies used interventions for drug packaging 
and of those, four had significantly better adherence in the 
intervention group over the control group.
Medications organized into packaging or blister 
packs with calendars, especially if combined with 
education and other reminding strategies, can help patients 
use their medications correctly, reducing medication errors 
(Zedler et al., 2011). Thus, care for the individual needs of 
the patient from the beginning of the therapy, combined 
with a differentiated system of dispensing drugs, with 
guidance, can motivate and increase the satisfaction of the 
patient, thereby promoting adherence.
The results obtained in the study allowed to state 
that the participants considered the use of DDSUC 
relevant to the improvement of adherence to the prescribed 
medication; participants also presented a high degree 
of satisfaction with the DDSUC. A similar result was 
achieved by Atozqui and Noguera (2004), who assessed 
the satisfaction degree of 112 elderly patients after the use 
of the “Sistema Personalizado de Dosificación (SPD)”. 
This system is available in Spain´s pharmacies and 
organizes the patients´ medications in a weekly package. 
The authors concluded that the use of the SPD reached a 
high degree of satisfaction among the users, what notably 
improved adherence to the prescribed treatment (Atozqui, 
Noguera, 2004).
The present study had limitations due to the small 
number of participants and short follow-up period. The 
DDSUC provides evidence on the overall impact on 
adherence, blood pressure, glycemia, GH, cholesterol 
and triglycerides, but cannot distinguish the impact of its 
individual components (blister packs versus guidance). 
Another limiting factor of the study was the lack of 
randomization and the control group.
However, most studies of intervention in adherence 
share methodology limitations, such as: lack of patient-
centered results, limited statistical power, sample size, 
short follow-up period and reliable adherence measures 
(Haynes et al., 2008; Pladevall et al., 2010).
Future research may enlarge the sample size and 
inclusion criteria. The study is significant because it may 
contribute to future researches that seek for new models 
of drug-dispensing systems, once we have not found in 
Brazil similar studies.
CONCLUSIONS
The DDSUC was designed to meet the needs of the 
population that has difficulty using their medications and, 
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likewise, to adhere to treatment. The study showed through 
the MGT and comparison of clinical parameters that the 
DDSUC improved adherence to therapy, promising to 
be a new model for optimizing complex treatments and 
ensuring patient safety.
Therefore, it is considered that the DDSUC had 
its relevance remarked in the study, and can be seen 
as an important tool for the current moment, when 
Brazil´s Health Ministry, especially its Department of 
Pharmaceutical Assistance, points out the importance 
to modify the practices for drug dispensation, ensuring 
not only the access, but also the information for the 
patients that receive their medication in the Health Units’ 
Pharmacies.
Promoting quality attention to polymedicated 
patients and implementing interventions that ensure 
adherence to drug treatment are actions that may provide 
the rational use of medication.
It is hoped that Brazil´s Unified Health System 
and the National Program for Pharmaceutical Assistance 
can rapidly implement educational and drug-dispensing 
interventions to ensure the adherence and rational use 
of drugs, decreasing hospital commitment caused by 
wrong therapeutics, as well as the expenses from such 
commitments.
The use of DDSUC improved adherence to drug 
treatment and decreased the values of blood pressure, 
providing the patient with more safety and satisfaction 
when it comes to organizing and correctly using their 
medication.
ACKNOWLEDGEMENTS
We thank the Center for Quantitative Methods 
(CEMEQ) of the Faculty of Medicine of Ribeirão Preto, 
University of São Paulo (FMRP/ USP), Prof. Dr. José 
Sebastião dos Santos, Prof. Dr. Eduardo Barbosa Coelho, 
Dr. Sonia Mara Neves Ferri and English teacher Abilio 
Borghi.
FUNDING
This work was supported by Conselho Nacional de 
Desenvolvimento Científico e Tecnológico (CNPq) and 
Coordenação de Aperfeiçoamento de Pessoal de Nível 
Superior (CAPES).
CONFLICTS OF INTEREST
None declared.
REFERENCES
AHMED, R.; ASLANI, p.What is patient adherence? A 
terminology overview. Int. J. Clin. Pharm., v.36, n.1, p.4-
7, 2014. 
ATOZQUI, J.; NOGUERA, A.D. Determinación del grado 
de satisfacción em el uso de um sistema personalizado de 
dosificación. Pharm. Care Esp., v.6, p.91-94, 2004.
BALDONI, A.O.; AYRES, L.R.; MARTINEZ, E.Z.; DEWULF, 
N.L.S.; SANTOS, V.; OBRELI-NETO, P.R.; PEREIRA, 
L.R.L. Pharmacoepidemiological profile and polypharmacy 
indicators in elderly outpatients. Braz. J. Pharm. Sci., v.49, 
n.3, p.443-452, 2013.
BEM, A.J.; NEUMANN, C.R.; MENGUE, S.S. Teste de 
Morisky-Green e Brief Medication Questionnaire para 
avaliar adesão a medicamentos. Rev. Saúde Pública, v.46, 
n.2, p.279-289, 2012.
BRAITHWAITE, S.; SHIRKHORSHIDIAN, I.; JONES, K.; 
JOHNSRUD, M. The Role of Medication Adherence in 
the U.S. Healthcare System. National Association of Chain 
Drug Stores (NACDS). June 2013. Available at: <http://
static.correofarmaceutico.com/docs/2013/06/24/adher.
pdf>. Accessed on: 23 Sept. 2013.
CAVALARI, E.; NOGUEIRA, M.S.; FAVA, S.M.C.L.; 
CESARINO, C.B.; MARTIN, J.F.V. Adesão ao tratamento: 
estudo entre portadores de hipertensão arterial em 
seguimento ambulatorial. Rev. enferm. UERJ, v.20, n.1, 
p.67-72, 2012. Available at: <http://www.facenf.uerj.br/
v20n1/v20n1a12.pdf>. Accessed on: 30 Jun. 2013.
CONNOR, J.; RAFTER, N., RODGERS, A. Do fixed-dose 
combination pills or unit-of-use packaging improve 
adherence? A systematic review. Bull. World Health Organ., 
v.82, n.12, p.935-939, 2004.
EID, L.P.; NOGUEIRA, M.S.; VEIGA, E.V.; CESARINO, E.J.; 
ALVES, L.M.M. Adesão ao tratamento anti-hipertensivo: 
análise pelo Teste de Morisky-Green. Rev. Eletr. Enf, v.15, 
n.2, p.362-367, 2013.
HAYNES, R.B.; ACKLOO, E.; SAHOTA, N.; MCDONALD, 
H.P.; YAO, X. Interventions for enhancing medication 
adherence. Cochrane Db. Syst. Rev., n.2, CD000011, 2008.
L. B. Vieira, J. Ueta, L. R. L. Pereira336
IBGE. INSTITUTO BRASILEIRO DE GEOGRAFIA E 
ESTATÍSTICA. Censo Demográfico, 2010. Rio de Janeiro: 
IBGE. Available at: <http://www.censo2010.ibge.gov.br/>. 
Accessed on: 13 Sept. 2013.
LEE, J.K.; GRACE, K.A.; TAYLOR, A.J. Effect of a pharmacy 
care program on medication adherence and persistence, 
blood pressure, and low-density lipoprotein cholesterol: 
a randomized controlled trial. JAMA, v.296, n.21, p.2563-
2571, 2006.
MICROMEDEX. Micromedex Healthcare Series [Internet]. 
Truven Health Analytics, 2007. Available at: http://www-
micromedexsolutions-com.ez67.periodicos.capes.gov.br/ 
micromedex2/librarian/. Accessed on: 15 Setp. 2007.
MORGADO, M.P.; MORGADO, S.R.; MENDES, L.C.; 
PEREIRA, L.J.; CASTELO-BRANCO, M. Pharmacist 
interventions to enhance blood pressure control and 
adherence to antihypertensive therapy: Review and meta-
analysis. Am. J. Health-Syst. Ph., v.68, n.3, p.241-253, 2011.
MORISKY, D.E.; GREEN, L.W.; LEVINE, D.M. Concurrent 
and predictive validity of a self-reported measure of 
medication adherence. Med. Care, v.24, n.1, p.67-74, 1986.
NAIR, K.V.; BELLETTI, D.A.; DOYLE, J.J.; ALLEN, R.R.; 
MCQUEEN, R.B.; SASEEN, J.J.; VANDE GRIEND, J.; 
PATEL, J.V.; MCQUEEN, A.; JAN, S. Understanding 
barriers to medication adherence in the hypertensive 
population by evaluating responses to a telephone survey. 
Patient Prefer Adherence, v.5, n.195, p.195-206, 2011.
NÓBREGA, O.T.; KARNIKOWSKI, M.G.O. A terapia 
medicamentosa no idoso: cuidados na medicação. Ciênc. 
Saúde Coletiva, v.10, n.2, p.309-313, 2005.
OSTERBERG, L.; BLASCHKE, T. Adherence to Medication. 
N. Engl. J. Med., v.353, p.487-497, 2005.
PLADEVALL, M.; BROTONS, C.; GABRIEL, R.; ARNAU, 
A.; SUAREZ, C.; DE LA FIGUERA, M.; MARQUEZ, E.; 
COCA, A.; SOBRINO, J.; DIVINE, G.; HEISLER, M.; 
WILLIAMS, L.K. Multicenter cluster-randomized trial of 
a multifactorial intervention to improve antihypertensive 
medication adherence and blood pressure control among 
patients at high cardiovascular risk (the COM99 study). 
Circulation, v.122, n.12, p.1183-1191, 2010.
RUPPAR, T.M.; CONN, V.S.; RUSSELL, C.L. Medication 
adherence interventions for older adults: literature review. 
Res. Theory Nurs. Pract., v.22, n.2, p.114-147, 2008.
SANTOS, M.V.R.; OLIVEIRA, D.C.; ARRAES, L.B.; 
OLIVEIRA, D.A.G.C.; LUZIDALVA MEDEIROS, L.; 
NOVAES, M.A. Adesão ao tratamento anti-hipertensivo: 
conceitos, aferição e estratégias inovadoras de abordagem. 
Rev. Bras. Clin. Med., v.11, n.1, p.55-61, 2013.
SECOLI, S.R. Polifarmácia: interações e reações adversas 
no uso de medicamentos por idosos. Rev. Bras. Enferm., 
v.63, n.1, p.136-140, 2010. Available at: <http://dx.doi.
org/10.1590/S0034-71672010000100022>. Accessed on: 
5 Sept. 2011.
SIMMONS, D.; UPJOHN, M.; GAMBLE, G.D. Can Medication 
Packaging Improve Glycemic Control and Blood Pressure 
in Type 2 Diabetes? Diabetes Care, v.23, n.2, p.153-156, 
2000.
SOCIEDADE BRASILEIRA DE DIABETES. Diretrizes da 
Sociedade Brasileira de Diabetes 2009. 3. ed. Itapevi, SP: 
A. Araújo Silva Farmacêutica, 2009. 400 p.
SOCIEDADE BRASILEIRA DE HIPERTENSÃO. Diretrizes 
Brasileiras de Hipertensão Arterial VI. Revista Hipertensão, 
v.13, n.1, p.1-68, 2010. Available at: <http://www.sbh.org.
br/pdf/diretrizes_final.pdf>. Acessed on: 5 Ago. 2011
SOKOL, M.C.; MCGUIGAN, K.A.; VERBRUGGE, R.R.; 
EPSTEIN, R.S. Impact of medication adherence on 
hospitalization risk and healthcare cost. Med. Care, v.43, 
p.521-530, 2005.
SPRIET, I.; MEERSSEMAN, W.; DE HOON, J.; VON 
WINCKELMANN, S.; WILMER, A.; WILLEMS, L. Mini-
series: II. Clinical aspects. Clinically relevant CYP450-
mediated drug interactions in the ICU. Intens. Care Med., 
v.35, n.4, p.603-612, 2009.
WOLFF, J.L.; STARFIELD, B.; ANDERSON, G. Prevalence, 
expenditures, and complications of multiple chronic 
conditions in the elderly. Arch. Intern. Med., v.162, p.2269-
2276, 2002.
WORLD HEALTH ORGANIZATION. WHO. Adherence to 
long-term therapies: evidence for action. Genebra, 2003.
Adherence to medication before and after the use of a Drug-Dispensing System with usage control 337
ZHANG, N.J.; TERRY, A.; MCHORNEY, C.A. Impact of health 
literacy on medication adherence: a systematic review and 
meta-analysis. Ann. Pharmacother., p.1-11, 2014.
ZEDLER, B.K.; KAKAD, P.; COLILLA, S.; MURRELLE, 
L.; SHAH, N.R. Does packaging with a calendar feature 
improve adherence to self-administered medication for 
long-term use? A systematic review. Clin. Ther., v.33, n.1, 
p.62-73, 2011.
Received for publication on 04th February 2014
Accepted for publication on 13th September 2014

